Home/ Stocks/ MNKD

Mannkind Corporation

MNKD XNAS

$3.90 +0.09 (+2.39%) ▲ 15-min delayed

Open

$3.92

High

$4.09

Low

$3.80

Volume

4.99M

Market Cap

$1.25B

About Mannkind Corporation

MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 592 Website →

Related Market News

No specific coverage for MNKD yet. Check out our latest market news or earnings calendar.

Get MNKD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Mannkind Corporation.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.